From those lacing up their trainers after losing weight to anyone considering medication as a route to faster race times, the use of GLP-1s in the running community is on the rise. But weighing any potential benefits with the inherent dangers is a delicate balancing act

We’ve all heard of Ozempic by now. It’s only licensed for use as an injectable diabetes treatment in the UK and US, but it’s widely used ‘off label’ to help people lose weight. So much so in fact, tha

Around 2.5 million people are currently taking weight-loss drugs in the UK. That’s almost 3.5% of the population injecting drugs such as Mounjaro and WeGovy and facing up to access barriers, price fluctuations and supply shortages. But, as four men explain, the hype around these drugs is very real

It wasn’t just me feeling lighter, my purse was too

From personalised treatments to new AI-powered tools, diabetes care is undergoing a revolution. We explain how to make recent developments work for you

Why 99% of eating plans fail and how to finally succeed!